REG - Abingdon Health PLC - Award of Options under LTIP
24/10/2023 07:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231024:nRSX0295Ra&default-theme=true
RNS Number : 0295R Abingdon Health PLC 24 October 2023
Abingdon Health plc
("Abingdon" or "the Company")
Award of Options under LTIP
York, U.K. 24 October 2023: Abingdon Health plc (AIM: ABDX), a leading
international developer and manufacturer of high quality, rapid diagnostic
tests, announces that, under the terms of the existing Long Term Incentive
Plan established in December 2022 ("LTIP" or the "Plan"), the Company has
awarded share options ("Options") over a total of 2,386,238 ordinary shares of
0.025 pence each ("Ordinary Shares") to certain directors and senior
management, in order to incentivise and encourage retention in a manner that
aligns with the interests of the Company's shareholders.
The Options are nil cost and will vest over a three-year vesting period.
Vesting of the Options is conditional upon the business achieving certain
challenging revenue, adj. EBITDA and total shareholder return criteria. The
Options will become exercisable between 24 October 2026 and 24 October 2033.
The following directors and members of the senior management team (each a
person discharging managerial responsibilities ("PDMR")) have been awarded
options:
PDMR Role No. of new Options awarded under the LTIP No. of existing Options under the LTIP Total number of Options under the LTIP
Chris Yates Chief Executive Officer 850,459 1,285,714 2,136,173
Chris Hand Non-Executive Chairman 283,486 428,571 712,057
Mark Jones Chief Operating Officer 401,376 600,000 1,001,376
Nina Garrett Chief Technical Officer 337,156 515,000 852,156
Candice Vendetuolli Head of QARA 183,486 285,714 469,200
Natalie Thrush Head of HR 68,807 90,000 158,807
Liam Currivan Head of Sales & Marketing 261,468 - 261,468
As a result of these changes, the Company now has outstanding options over
5,719,162 Ordinary Shares equal to approximately 4.7 per cent. of the
Company's issued share capital.
Enquiries:
Abingdon Health plc www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
Chris Yates, Chief Executive Officer Via Walbrook PR
Chris Hand, Non-Executive Chairman
Singer Capital Markets (Sole Broker and Nominated Adviser) Tel: +44 (0)20 7496 3000
Peter Steel, Alex Bond, Jalini Kalaravy
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
(mailto:abingdon@walbrookpr.com)
Paul McManus / Phillip Marriage Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082
Alice Woodings +44 (0)7407 804 654
About Abingdon Health plc
Abingdon Health is a leading lateral flow contract research (CRO) and
contract development and manufacturing organisation ("CDMO") offering its
services to an international customer base across industry sectors that
include clinical, animal health, plant health, and environmental testing.
Abingdon Health has the internal capabilities to take projects from initial
concept through to routine and large-scale manufacturing; from "idea to
commercial success."
The Company's CDMO division offers product development, regulatory support,
technology transfer and manufacturing services for customers looking to
develop new assays or transfer existing laboratory-based assays to a lateral
flow format. Abingdon Health aims to support the increase in need for rapid
results across many industries and locations and produces lateral flow tests
in areas such as infectious disease, clinical testing including companion
diagnostics, animal health and environmental testing. Faster access to results
allows for rapid decision making, targeted intervention and can support better
outcomes.
Abingdon Health's Abingdon Simply Test™ range of self-tests is an ecommerce
platform that offers a range of self-tests to empowers consumers to manage
their own health and wellbeing. The Abingdon Simply Test
(http://www.abingdonsimplytest.com) ™ ecommerce site offers consumers a
range of information to support them in making informed decisions on the tests
available. In addition, the site provides Abingdon's contract services
customers with a potential route to market for self-tests. The Abingdon Simply
Test range is also sold through international distributors and through other
channels in the UK and Ireland such as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York, England.
For more information visit: www.abingdonhealth.com
(http://www.abingdonhealth.com/)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Chris Yates
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil-cost 850,459
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr Chris Hand
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 283,486
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mark Jones
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 401,376
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Nina Garrett
2 Reason for the notification
a) Position/status Chief Technical Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 337,156
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Candice Vendetuolli
2 Reason for the notification
a) Position/status Head of QARA
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 183,486
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Natalie Thrush
2 Reason for the notification
a) Position/status Head of HR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 68,807
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Liam Currivan
2 Reason for the notification
a) Position/status Head of Sales & Marketing
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.025 pence each
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 261,468
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHMZMZGGFVGFZZRecent news on Abingdon Health
See all newsREG - Abingdon Health PLC - Design freeze completion & strategic partnership
AnnouncementREG - Abingdon Health PLC - Launch of OEM self-tests in Boots
AnnouncementRCS - Abingdon Health PLC - CEO Interview
AnnouncementREG - Abingdon Health PLC - Interim Results
AnnouncementREG - Abingdon Health PLC - Notice of Results
Announcement